( in Million)
Particulars
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
14674.2
16320.3
17662.7
17689.8
Total Expenditure
11729.1
13178
14560.2
14363.1
PBIDT (Excl OI)
2945.1
3142.3
3102.5
3326.7
Other Income
335
239.3
359.8
111.7
Operating Profit
3280.1
3381.6
3462.3
3438.4
Exceptional Items
NA
NA
NA
NA
PBDT
3172.1
3259.2
3323.3
3328.1
Depreciation
542.1
538.2
532.3
520.8
Profit Before Tax
2630
2721
2791
2807.3
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
2086
2180.3
2127
2045.5
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
2086
2180.3
2127
2045.5
Minority Interest
NA
NA
NA
NA
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
2086
2180.3
2127
2045.5
Equity Capital
341.8
341.8
341.8
341.8
Calculated EPS
6.10
6.37
6.22
5.98
Calculated EPS (Annualised)
24.41
25.51
24.89
23.93
No of Public Share Holdings
111007884
111007884
111007884
100207884
% of Public Share Holdings
32.48
32.48
32.48
29.32
PBIDTM% (Excl OI)
20.06
19.25
17.56
18.80
PBIDTM%
22.35
20.72
19.60
19.43
PBDTM%
21.61
19.97
18.81
18.81
PBTM%
17.92
16.67
15.80
15.86
PATM%
14.21
13.35
12.04
11.56